A heat-shocked melanoma cell lysate vaccine enhances tumor infiltration by prototypic effector T cells inhibiting tumor growth
Background Immune checkpoint blocker (ICB) therapy has shown survival benefits for some patients with cancer. Nevertheless, many individuals remain refractory or acquire resistance to treatment, motivating the exploration of complementary immunotherapies. Accordingly, cancer vaccines offer an attrac...
Saved in:
| Main Authors: | María Alejandra Gleisner, Cristián Pereda, Andrés Tittarelli, Mariela Navarrete, Camila Fuentes, Ignacio Ávalos, Fabian Tempio, Juan Pablo Araya, María Inés Becker, Fermín Eduardo González, Mercedes Natalia López, Flavio Salazar-Onfray |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e000999.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From Tumor Immunosuppression to Eradication: Targeting Homing and Activity of Immune Effector Cells to Tumors
by: Oana Draghiciu, et al.
Published: (2011-01-01) -
Correction: MRI of tumor T cell infiltration in response to checkpoint inhibitor therapy
Published: (2020-10-01) -
Prediction of CD8+ T cell infiltration in the tumor microenvironment of HGSOC patients
by: Jia Mai, et al.
Published: (2025-08-01) -
Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines
by: Cynthia González Muñoz, et al.
Published: (2025-05-01) -
Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration
by: Juan Wu, et al.
Published: (2020-10-01)